載入...
Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies
SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) constitute a paradigm shift in cancer therapy, and it has greatly expanded our knowledge of anticancer immunity and has introduced breakthroughs in cancer therapy. However, despite the promising results in the use of immunotherapy in some cancers,...
Na minha lista:
| 發表在: | Cancers (Basel) |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7998672/ https://ncbi.nlm.nih.gov/pubmed/33801815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061188 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|